| Product |
Indication |
Target |
Status |
More Information |
EG12014/EGI014
Trastuzumab Biosimilar |
Cancer |
HER2 |
Phase III |
For more information click here |
Her2 Family Products
 |
EG1206A
Pertuzumab Biosimilar |
Cancer |
HER2 |
Preclinical |
|
EG13074
New Formulation |
Cancer |
HER2 |
Preclinical |
|
TSY0110(EG12043)
Antibody-Drug Conjugate |
Cancer |
HER2 |
Preclinical |
|
EG12021
Bevacizumab Biosimilar |
Cancer |
VEGF |
Preclinical |
|
EG74032
CRM197 Carrier Protein |
- |
Carrier protein for conjugate vaccines |
GMP manufacturing |
|
EG62054
Biosimilar |
Undisclosed |
Undisclosed |
Preclinical |
|